Monovisc Pregnancy Warnings
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.
Safety has not been established.
US FDA pregnancy category: Not assigned.
Risk Summary: Safety and effectiveness of this drug have not been established in pregnancy.
See references
